<DOC>
	<DOC>NCT00955097</DOC>
	<brief_summary>The primary purpose of this study is to demonstrate the safety and effectiveness of using an intra-operative ultrasound contrast agent(Definity®) for the identification of known liver tumors.</brief_summary>
	<brief_title>Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors</brief_title>
	<detailed_description>The primary objective of this study is to demonstrate the safety of the use of intra-operative ultrasound contrast (Definity®) administration. The secondary objective of this study is to demonstrate the improved image quality and conspicuity of known liver tumors using contrast enhancement.</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>1. Undergoing a hepatic resection or hepatic ablation of preoperative visualized liver tumor: 2. ≥ 18 years of age 3. If female of childbearing potential, negative pregnancy test within 14 days prior to surgery 4. If subject is a sexually active male or a sexually active female of childbearing potential, subject agrees to use a medically accepted form of contraception from the time of enrollment to completion of all followup study visits. 5. IRBapproved informed consent, signed by the subject or the subject's legally authorized representative. ≥ 18 years of age 1. Not a suitable candidate for operation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Definity</keyword>
	<keyword>liver tumors</keyword>
	<keyword>intra operative contrast</keyword>
	<keyword>liver cancer</keyword>
	<keyword>hepatic tumors</keyword>
	<keyword>identify liver tumors</keyword>
	<keyword>surgery liver tumors</keyword>
	<keyword>Patients with known hepatic tumors</keyword>
</DOC>